Pricing Log in Create free account

Celularity, Inc. (CELU) vs CervoMed Inc. (CRVO)

Celularity, Inc. and CervoMed Inc. are both Biotechnology companies. Celularity, Inc. and CervoMed Inc. are of similar size ($23.5M and $21.9M). Celularity, Inc. grew revenue faster over the last twelve months: −58.1% against −58.9%. CervoMed Inc. has the higher net margin (0.00% vs −247.7%) and the higher return on invested capital (0.00% vs −462.8%). Across the 16 metrics below, Celularity, Inc. leads on 9 and CervoMed Inc. on 7.

Valuation

Metric CELU CRVO Biotechnology median
P/E n/m n/m 10.60
P/S 1.19 3.61 9.40
P/B n/m 0.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 3.45 0.62 9.02
Earnings yield (222.37%) (228.37%) (32.88%)
Free cash flow yield (40.93%) (196.71%) (23.13%)

Profitability

Metric CELU CRVO Biotechnology median
Gross margin 19.23% 100.00% 68.51%
Operating margin (264.27%) 0.00% 0.00%
Net margin (247.71%) 0.00% 0.00%
Free cash flow margin (47.80%) 0.00% 0.00%
Return on equity 151.53% (107.62%) (51.96%)
Return on assets (42.72%) (94.73%) (46.06%)
Return on invested capital (462.77%) 0.00% 0.00%

Growth

Metric CELU CRVO Biotechnology median
Revenue growth (TTM) (58.14%) (58.86%) 6.76%
EPS growth (last fiscal year) (35.98%) (47.52%) 29.88%
Revenue growth, 5-year CAGR 13.21% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELU CRVO Biotechnology median
Debt to equity (1.20) 0.00 0.00
Current ratio 0.11 8.57 4.97
Net debt to EBITDA (0.77) 0.74 1.01

Dividend

Metric CELU CRVO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CELU CRVO Biotechnology median
Market cap 23.54m 21.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack